The Danish life sciences & healthcare industry has developed significantly over the past decade, and today the industry is one of Denmark’s most important business strengths.
Our Life Sciences group has a deep understanding of the challenges that life sciences companies are facing in light of recent geopolitical tensions, the introduction of new technologies, the increasing regulatory complexities within the industry, and an ever-changing competitive landscape.
With extensive knowledge of both national and international regulatory environments and commercial realities, our dedicated Life Sciences team provides specialized advice to both Danish and foreign clients within all areas of the Life Sciences industry, including within:
We provide advice to a broad range of clients in all aspects throughout both corporate and product lifecycles — from early-stage discovery, research and development, over clinical trials and product evaluations, product approvals, market access, manufacture, distribution, marketing, and to post-market compliance.
Also, we assist Life Sciences businesses and their owners and investors in raising capital and investments and with the acquisition and sale of Life Sciences businesses.
At Gorrissen Federspiel, we pride ourselves on being at the forefront of regulatory and legal developments in Denmark and the EU. Our dedicated team of lawyers stays abreast of the latest changes in legislation and regulatory frameworks, ensuring that our clients receive cutting-edge advice that reflects the current legal landscape.
Our Life Sciences group integrates 50+ years of top-tier legal expertise with deep industry insight, offering bespoke advice that meets the specific needs of clients, advising within a wide range of areas, including:
We have deep insight into the regulatory environment from team members having experience from the EU Commission, the Danish Medicines Agency, the Danish Veterinary and Food Administration, and rights granting bodies like EUIPO. This allows us to provide pragmatic and actionable guidance that helps clients navigate complex regulations.
As a full-service law firm – and through collaboration across practice groups – we deliver timely, comprehensive solutions that address every aspect of our clients’ operations. We pride ourselves on strategic thinking and delivering commercially driven advice that supports our clients’ business objectives.
At the 2025 EMEA Awards, LMG Life Sciences named Gorrissen Federspiel “Denmark Firm of the Year” as well as a winner in the “Impact Deal of the Year” category.
Kantar Sifo Prospera ranked Gorrissen Federspiel as the #1 law firm in Denmark for “Best Legal Competence” in life sciences, according to their 2025 Tier 1 Law Firm Review of the Danish legal market.